Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-023-01198-0, published online 12 December 2023

The authors would like to apologize for the errors in the previously published images of Fig. 6a. These inaccuracies resulted from an oversight during figure preparation. The authors have thoroughly reviewed the original data and corrected these figures that were inadvertently misrepresented.

The corrected versions of the affected figure are now presented. It is important to note that these corrections do not alter the findings or conclusions of the paper. The overall interpretation and impact of the significance of the research remain unchanged.

The authors express their sincere apologies for any inconvenience this may have caused to the journal and its readers. They are appreciated to the understanding and support of the editorial team and the readers in rectifying these errors.

Correct Figure 6a

Figure 6a Representative immunofluorescence staining (a1) and quantification (a2) of Ki67 in cardiomyocytes 24 h after recombinant CCL2 treatment (100 ng/mL) with or without PF-4136309 (30 μM), a CCR2 antagonist (n = 6, ns. not significant, ***P < 0.001, scale bar = 50 μm).